Aspen Select Healthcare LP
10% Owner

Aspen Select Healthcare LP insider trades: Neogenomics (NEO) stock sales

10% Owner, Neogenomics Last trade Nov 27, 2015 8 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2012
2
Companies
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Aspen Select Healthcare LP reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 27, 2015NEO↓ Sell$1.4M
Nov 25, 2015NEO↓ Sell$1.7M
Nov 25, 2013NEO↓ Sell$389K
Nov 25, 2013NEO↓ Sell$16K
Apr 30, 2013NEO↓ Sell$371K
Dec 20, 2012NGNM.OB↓ Sell$1.8M
Sep 28, 2012NGNM.OB↓ Sell$184K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NEO insiders

Open-market trades in the last 12 months

About Aspen Select Healthcare LP's insider trades

Aspen Select Healthcare LP is a 10% owner of Neogenomics (NEO). Since Sep 28, 2012, it has reported no open-market purchases and 7 sales worth $5.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include gifts (3 filings), grants and awards (2 filings), other transactions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.